These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


668 related items for PubMed ID: 25001948

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer.
    Daouacher G, von Below C, Gestblom C, Ahlström H, Grzegorek R, Wassberg C, Sörensen J, Waldén M.
    BJU Int; 2016 Jul; 118(1):77-83. PubMed ID: 26074275
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.
    Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter CO, Lotz J, Schildhaus HU, Trojan L, Sahlmann CO.
    Prostate; 2015 Dec; 75(16):1934-40. PubMed ID: 26356236
    [Abstract] [Full Text] [Related]

  • 9. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A, Abdollah F, Nini A, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Passoni NM, Salonia A, Colombo R, Freschi M, Rigatti P, Montorsi F.
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [Abstract] [Full Text] [Related]

  • 10. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E.
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    Budiharto T, Joniau S, Lerut E, Van den Bergh L, Mottaghy F, Deroose CM, Oyen R, Ameye F, Bogaerts K, Haustermans K, Van Poppel H.
    Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
    [Abstract] [Full Text] [Related]

  • 13. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
    de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ.
    J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
    [Abstract] [Full Text] [Related]

  • 14. Histological Validation of 11Carbon-Acetate Positron Emission Tomography/Computerized Tomography in Detecting Lymph Node Metastases in Prostate Cancer.
    Rajarubendra N, Almeida F, Manojlovic Z, Ohe C, Ahmadi N, Cacciamani G, Qiu M, Abreu A, Cai J, Miranda G, Stern MC, Carpten J, Kuhn P, Amin MB, Gill PS, Aron M, Gill IS.
    J Urol; 2019 Feb; 201(2):332-341. PubMed ID: 30218760
    [Abstract] [Full Text] [Related]

  • 15. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z, Liu Q, Li M, Han M, Yao S, Liu Q.
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [Abstract] [Full Text] [Related]

  • 16. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
    Oderda M, Joniau S, Palazzetti A, Falcone M, Melloni G, Van Den Bossche H, Deconinck S, Zattoni F, Karnes RJ, Gontero P.
    Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893
    [Abstract] [Full Text] [Related]

  • 17. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D, Schlemmer HP, Wagner PH, Böttcher P, Merseburger AS, Aschoff P, Bares R, Pfannenberg C, Ganswindt U, Corvin S, Stenzl A.
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [Abstract] [Full Text] [Related]

  • 18. FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy.
    Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS.
    Ann Surg Oncol; 2015 Sep; 22(9):3150-6. PubMed ID: 25634779
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic Accuracy of 64Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience.
    Cantiello F, Gangemi V, Cascini GL, Calabria F, Moschini M, Ferro M, Musi G, Butticè S, Salonia A, Briganti A, Damiano R.
    Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628
    [Abstract] [Full Text] [Related]

  • 20. Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.
    Passoni NM, Suardi N, Abdollah F, Picchio M, Giovacchini G, Messa C, Freschi M, Montorsi F, Briganti A.
    Urol Oncol; 2014 Jan; 32(1):38.e9-16. PubMed ID: 23769269
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.